HEADER HYDROLASE 17-DEC-14 4UEE TITLE CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH THE TITLE 2 PHOSPHINIC INHIBITOR ACETYL-LEU-ALA-Y(PO2CH2)-HOMOPHE-OH COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARBOXYPEPTIDASE A1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CARBOXYPEPTIDASE DOMAIN, RESIDUES 111-4189; COMPND 5 EC: 3.4.17.1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: IN COMPLEX WITH THE PHOSPHINIC INHIBITOR ACETYL-LEU- COMPND 8 ALA-Y(PO2CH2)-HOMOPHE-OH. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: PANCREAS; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: KM71H; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PPICZ-ALPHA KEYWDS HYDROLASE, CPA1, PHOSPHINIC INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR P.GALLEGO,G.COVALEDA,L.COSTENARO,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER REVDAT 2 20-DEC-23 4UEE 1 REMARK LINK REVDAT 1 20-JAN-16 4UEE 0 JRNL AUTH P.GALLEGO,G.COVALEDA,L.DEVEL,V.DIVE,F.X.AVILES,D.REVERTER JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN JRNL TITL 2 COMPLEX WITH PHOSPHINIC INHIBITORS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 3 NUMBER OF REFLECTIONS : 23935 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1279 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.27 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.33 REMARK 3 REFLECTION IN BIN (WORKING SET) : 861 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 44.77 REMARK 3 BIN R VALUE (WORKING SET) : 0.1790 REMARK 3 BIN FREE R VALUE SET COUNT : 54 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4865 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 259 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.26000 REMARK 3 B22 (A**2) : -2.15000 REMARK 3 B33 (A**2) : -0.11000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.254 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.152 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.630 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5065 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6896 ; 1.672 ; 1.944 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 611 ; 6.529 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 227 ;33.819 ;23.921 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 789 ;14.470 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 19 ;16.424 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 755 ; 0.105 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3865 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3043 ; 1.148 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4922 ; 2.009 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2022 ; 3.349 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1974 ; 5.093 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 5065 ; 1.747 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 308 REMARK 3 ORIGIN FOR THE GROUP (A): -4.4809 1.9113 -16.2291 REMARK 3 T TENSOR REMARK 3 T11: 0.0583 T22: 0.0286 REMARK 3 T33: 0.0006 T12: -0.0001 REMARK 3 T13: -0.0002 T23: -0.0002 REMARK 3 L TENSOR REMARK 3 L11: 0.0152 L22: -0.0001 REMARK 3 L33: 0.0345 L12: -0.0015 REMARK 3 L13: 0.0005 L23: 0.0012 REMARK 3 S TENSOR REMARK 3 S11: -0.0004 S12: 0.0001 S13: -0.0008 REMARK 3 S21: -0.0015 S22: 0.0003 S23: 0.0013 REMARK 3 S31: 0.0008 S32: -0.0010 S33: 0.0001 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 3 B 308 REMARK 3 ORIGIN FOR THE GROUP (A): -11.9284 38.9740 -22.9249 REMARK 3 T TENSOR REMARK 3 T11: 0.0595 T22: 0.0273 REMARK 3 T33: -0.0002 T12: 0.0001 REMARK 3 T13: 0.0040 T23: 0.0017 REMARK 3 L TENSOR REMARK 3 L11: 0.0198 L22: 0.0586 REMARK 3 L33: 0.0314 L12: -0.0102 REMARK 3 L13: -0.0088 L23: 0.0097 REMARK 3 S TENSOR REMARK 3 S11: 0.0053 S12: 0.0023 S13: -0.0003 REMARK 3 S21: -0.0110 S22: -0.0043 S23: -0.0025 REMARK 3 S31: -0.0024 S32: -0.0024 S33: -0.0011 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4UEE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062596. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALBA REMARK 200 BEAMLINE : XALOC REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979471 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XPS REMARK 200 DATA SCALING SOFTWARE : CCP4I REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25246 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 46.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.6 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.13000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2V77 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.11 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M CALCIUM CHLORIDE, 0.1 M HEPES PH REMARK 280 7.0 AND 20% W/V PEG6000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.14900 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.54800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.99150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.54800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.14900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.99150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -87.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 TYR A 309 REMARK 465 ALA B 1 REMARK 465 ARG B 2 REMARK 465 TYR B 309 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2101 O HOH A 2102 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 122 -52.04 -133.96 REMARK 500 SER A 199 -16.61 150.07 REMARK 500 GLN A 200 63.34 66.18 REMARK 500 ILE A 247 -75.48 -125.58 REMARK 500 ASP A 273 -141.59 -102.53 REMARK 500 LEU A 280 40.93 -92.52 REMARK 500 ASN B 29 52.22 -142.57 REMARK 500 LYS B 58 55.57 31.69 REMARK 500 THR B 122 -46.41 -134.96 REMARK 500 ASP B 148 47.42 -77.52 REMARK 500 ASN B 188 34.95 -150.83 REMARK 500 SER B 199 -15.75 148.77 REMARK 500 GLN B 200 65.17 61.80 REMARK 500 ILE B 247 -70.14 -132.27 REMARK 500 LEU B 271 -169.33 -79.98 REMARK 500 ASP B 273 -139.14 -110.83 REMARK 500 LEU B 280 38.66 -89.55 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A1310 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 69 ND1 REMARK 620 2 GLU A 72 OE2 103.0 REMARK 620 3 HIS A 196 ND1 102.1 134.5 REMARK 620 4 LA9 A1309 O16 126.0 100.2 94.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B1310 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 69 ND1 REMARK 620 2 GLU B 72 OE2 100.8 REMARK 620 3 HIS B 196 ND1 103.2 130.5 REMARK 620 4 LA9 B1309 O16 122.1 95.7 106.8 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: NULL REMARK 630 MOLECULE NAME: (2S)-2-{[(R)-{(1R)-1-[(N-ACETYL-L-LEUCYL)AMINO] REMARK 630 ETHYL}(HYDROXY)PHOSPHORYL]METHYL}-4-PHENYLBUTANOIC ACID REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 LA9 A 1309 REMARK 630 LA9 B 1309 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: ACY LEU WN6 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LA9 A 1309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 1310 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LA9 B 1309 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 1310 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UEF RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 THE PHOSPHINIC INHBITOR ACETYL-TYR-ALA-Y (PO2CH2)-HOMOPHE-OH REMARK 900 RELATED ID: 4UEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 THE PHOSPHINIC INHIBITOR ACETYL-LEU-PHE-Y (PO2CH2)-PHE-OH REMARK 900 RELATED ID: 4UF4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CARBOXYPEPTIDASE A1 IN COMPLEX WITH REMARK 900 A THIIRANE MECHANISM-BASED INHIBITOR REMARK 900 RELATED ID: 5AEK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN SENP2 C548S IN COMPLEX WITH THE REMARK 900 HUMAN SUMO1 K48M F66W DBREF 4UEE A 1 309 UNP P15085 CBPA1_HUMAN 111 419 DBREF 4UEE B 1 309 UNP P15085 CBPA1_HUMAN 111 419 SEQRES 1 A 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 A 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 A 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 A 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 A 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 A 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 A 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 A 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 A 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 A 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 A 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 A 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 A 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 A 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 A 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 A 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 A 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 A 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 A 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 A 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 A 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 A 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 A 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 A 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR SEQRES 1 B 309 ALA ARG SER THR ASP THR PHE ASN TYR ALA THR TYR HIS SEQRES 2 B 309 THR LEU GLU GLU ILE TYR ASP PHE LEU ASP LEU LEU VAL SEQRES 3 B 309 ALA GLU ASN PRO HIS LEU VAL SER LYS ILE GLN ILE GLY SEQRES 4 B 309 ASN THR TYR GLU GLY ARG PRO ILE TYR VAL LEU LYS PHE SEQRES 5 B 309 SER THR GLY GLY SER LYS ARG PRO ALA ILE TRP ILE ASP SEQRES 6 B 309 THR GLY ILE HIS SER ARG GLU TRP VAL THR GLN ALA SER SEQRES 7 B 309 GLY VAL TRP PHE ALA LYS LYS ILE THR GLN ASP TYR GLY SEQRES 8 B 309 GLN ASP ALA ALA PHE THR ALA ILE LEU ASP THR LEU ASP SEQRES 9 B 309 ILE PHE LEU GLU ILE VAL THR ASN PRO ASP GLY PHE ALA SEQRES 10 B 309 PHE THR HIS SER THR ASN ARG MET TRP ARG LYS THR ARG SEQRES 11 B 309 SER HIS THR ALA GLY SER LEU CYS ILE GLY VAL ASP PRO SEQRES 12 B 309 ASN ARG ASN TRP ASP ALA GLY PHE GLY LEU SER GLY ALA SEQRES 13 B 309 SER SER ASN PRO CYS SER GLU THR TYR HIS GLY LYS PHE SEQRES 14 B 309 ALA ASN SER GLU VAL GLU VAL LYS SER ILE VAL ASP PHE SEQRES 15 B 309 VAL LYS ASP HIS GLY ASN ILE LYS ALA PHE ILE SER ILE SEQRES 16 B 309 HIS SER TYR SER GLN LEU LEU MET TYR PRO TYR GLY TYR SEQRES 17 B 309 LYS THR GLU PRO VAL PRO ASP GLN ASP GLU LEU ASP GLN SEQRES 18 B 309 LEU SER LYS ALA ALA VAL THR ALA LEU ALA SER LEU TYR SEQRES 19 B 309 GLY THR LYS PHE ASN TYR GLY SER ILE ILE LYS ALA ILE SEQRES 20 B 309 TYR GLN ALA SER GLY SER THR ILE ASP TRP THR TYR SER SEQRES 21 B 309 GLN GLY ILE LYS TYR SER PHE THR PHE GLU LEU ARG ASP SEQRES 22 B 309 THR GLY ARG TYR GLY PHE LEU LEU PRO ALA SER GLN ILE SEQRES 23 B 309 ILE PRO THR ALA LYS GLU THR TRP LEU ALA LEU LEU THR SEQRES 24 B 309 ILE MET GLU HIS THR LEU ASN HIS PRO TYR HET LA9 A1309 30 HET ZN A1310 1 HET LA9 B1309 30 HET ZN B1310 1 HETNAM LA9 (2S)-2-{[(R)-{(1R)-1-[(N-ACETYL-L-LEUCYL) HETNAM 2 LA9 AMINO]ETHYL}(HYDROXY)PHOSPHORYL]METHYL}-4- HETNAM 3 LA9 PHENYLBUTANOIC ACID HETNAM ZN ZINC ION HETSYN LA9 ACETYL-LEU-ALA-Y(PO2CH2)-HOMOPHE-OH FORMUL 3 LA9 2(C21 H33 N2 O6 P) FORMUL 4 ZN 2(ZN 2+) FORMUL 7 HOH *259(H2 O) HELIX 1 1 THR A 14 ASN A 29 1 16 HELIX 2 2 GLU A 72 TYR A 90 1 19 HELIX 3 3 ASP A 93 ASP A 101 1 9 HELIX 4 4 ASN A 112 THR A 122 1 11 HELIX 5 5 ASP A 142 ASN A 146 5 5 HELIX 6 6 GLU A 173 GLY A 187 1 15 HELIX 7 7 ASP A 215 LEU A 233 1 19 HELIX 8 8 ILE A 243 ILE A 247 1 5 HELIX 9 9 SER A 253 GLN A 261 1 9 HELIX 10 10 PRO A 282 SER A 284 5 3 HELIX 11 11 GLN A 285 HIS A 307 1 23 HELIX 12 12 THR B 14 ASN B 29 1 16 HELIX 13 13 GLU B 72 TYR B 90 1 19 HELIX 14 14 ASP B 93 ASP B 101 1 9 HELIX 15 15 ASN B 112 THR B 122 1 11 HELIX 16 16 GLU B 173 GLY B 187 1 15 HELIX 17 17 ASP B 215 LEU B 233 1 19 HELIX 18 18 ILE B 243 ILE B 247 1 5 HELIX 19 19 SER B 253 GLN B 261 1 9 HELIX 20 20 TYR B 277 LEU B 281 5 5 HELIX 21 21 PRO B 282 SER B 284 5 3 HELIX 22 22 GLN B 285 ASN B 306 1 22 SHEET 1 AA 8 VAL A 33 ASN A 40 0 SHEET 2 AA 8 PRO A 46 PHE A 52 -1 O ILE A 47 N ILE A 38 SHEET 3 AA 8 ASP A 104 GLU A 108 -1 O ILE A 105 N PHE A 52 SHEET 4 AA 8 ALA A 61 THR A 66 1 O ILE A 62 N PHE A 106 SHEET 5 AA 8 ILE A 189 HIS A 196 1 N LYS A 190 O ALA A 61 SHEET 6 AA 8 TYR A 265 GLU A 270 1 O TYR A 265 N PHE A 192 SHEET 7 AA 8 LEU A 201 TYR A 204 -1 O LEU A 201 N GLU A 270 SHEET 8 AA 8 ASN A 239 SER A 242 1 O ASN A 239 N LEU A 202 SHEET 1 BA 8 VAL B 33 ASN B 40 0 SHEET 2 BA 8 PRO B 46 PHE B 52 -1 O ILE B 47 N ILE B 38 SHEET 3 BA 8 ASP B 104 GLU B 108 -1 O ILE B 105 N PHE B 52 SHEET 4 BA 8 ALA B 61 THR B 66 1 O ILE B 62 N PHE B 106 SHEET 5 BA 8 ILE B 189 HIS B 196 1 N LYS B 190 O ALA B 61 SHEET 6 BA 8 TYR B 265 GLU B 270 1 O TYR B 265 N PHE B 192 SHEET 7 BA 8 LEU B 201 TYR B 204 -1 O LEU B 201 N GLU B 270 SHEET 8 BA 8 ASN B 239 SER B 242 1 O ASN B 239 N LEU B 202 SSBOND 1 CYS A 138 CYS A 161 1555 1555 2.07 SSBOND 2 CYS B 138 CYS B 161 1555 1555 2.06 LINK ND1 HIS A 69 ZN ZN A1310 1555 1555 1.92 LINK OE2 GLU A 72 ZN ZN A1310 1555 1555 1.83 LINK ND1 HIS A 196 ZN ZN A1310 1555 1555 1.97 LINK O16 LA9 A1309 ZN ZN A1310 1555 1555 2.07 LINK ND1 HIS B 69 ZN ZN B1310 1555 1555 2.10 LINK OE2 GLU B 72 ZN ZN B1310 1555 1555 1.93 LINK ND1 HIS B 196 ZN ZN B1310 1555 1555 2.05 LINK O16 LA9 B1309 ZN ZN B1310 1555 1555 2.04 CISPEP 1 SER A 197 TYR A 198 0 8.19 CISPEP 2 PRO A 205 TYR A 206 0 -6.48 CISPEP 3 ARG A 272 ASP A 273 0 -5.16 CISPEP 4 SER B 197 TYR B 198 0 3.07 CISPEP 5 PRO B 205 TYR B 206 0 -5.36 CISPEP 6 ARG B 272 ASP B 273 0 -2.28 SITE 1 AC1 17 HIS A 69 ARG A 71 GLU A 72 ARG A 127 SITE 2 AC1 17 ASN A 144 ARG A 145 HIS A 196 TYR A 198 SITE 3 AC1 17 ILE A 243 TYR A 248 SER A 253 THR A 268 SITE 4 AC1 17 GLU A 270 PHE A 279 ZN A1310 HOH A2047 SITE 5 AC1 17 GLU B 163 SITE 1 AC2 4 HIS A 69 GLU A 72 HIS A 196 LA9 A1309 SITE 1 AC3 17 GLU A 163 HIS B 69 ARG B 71 GLU B 72 SITE 2 AC3 17 ARG B 127 ASN B 144 ARG B 145 HIS B 196 SITE 3 AC3 17 SER B 197 TYR B 198 ILE B 243 TYR B 248 SITE 4 AC3 17 THR B 268 GLU B 270 PHE B 279 ZN B1310 SITE 5 AC3 17 HOH B2050 SITE 1 AC4 4 HIS B 69 GLU B 72 HIS B 196 LA9 B1309 CRYST1 46.298 83.983 157.096 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021599 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011907 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006366 0.00000